Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $181.59 million. The enterprise value is $23.49 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CRBU has 93.12 million shares outstanding. The number of shares has increased by 4.28% in one year.
Current Share Class | 93.12M |
Shares Outstanding | 93.12M |
Shares Change (YoY) | +4.28% |
Shares Change (QoQ) | +0.38% |
Owned by Insiders (%) | 4.70% |
Owned by Institutions (%) | 45.00% |
Float | 83.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.63 |
Forward PS | 22.16 |
PB Ratio | 1.09 |
P/TBV Ratio | 1.09 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.58 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.66, with a Debt / Equity ratio of 0.16.
Current Ratio | 6.66 |
Quick Ratio | 6.46 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.93% and return on invested capital (ROIC) is -35.65%.
Return on Equity (ROE) | -68.93% |
Return on Assets (ROA) | -31.77% |
Return on Invested Capital (ROIC) | -35.65% |
Return on Capital Employed (ROCE) | -78.62% |
Revenue Per Employee | $62,048 |
Profits Per Employee | -$1.12M |
Employee Count | 147 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -9,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.41% in the last 52 weeks. The beta is 2.55, so CRBU's price volatility has been higher than the market average.
Beta (5Y) | 2.55 |
52-Week Price Change | +5.41% |
50-Day Moving Average | 1.63 |
200-Day Moving Average | 1.47 |
Relative Strength Index (RSI) | 53.89 |
Average Volume (20 Days) | 1,725,291 |
Short Selling Information
The latest short interest is 3.90 million, so 4.18% of the outstanding shares have been sold short.
Short Interest | 3.90M |
Short Previous Month | 4.62M |
Short % of Shares Out | 4.18% |
Short % of Float | 4.64% |
Short Ratio (days to cover) | 2.09 |
Income Statement
In the last 12 months, CRBU had revenue of $9.12 million and -$164.26 million in losses. Loss per share was -$1.79.
Revenue | 9.12M |
Gross Profit | -119.86M |
Operating Income | -150.95M |
Pretax Income | -123.25M |
Net Income | -164.26M |
EBITDA | -146.26M |
EBIT | -150.95M |
Loss Per Share | -$1.79 |
Full Income Statement Balance Sheet
The company has $183.95 million in cash and $25.85 million in debt, giving a net cash position of $158.10 million or $1.70 per share.
Cash & Cash Equivalents | 183.95M |
Total Debt | 25.85M |
Net Cash | 158.10M |
Net Cash Per Share | $1.70 |
Equity (Book Value) | 166.13M |
Book Value Per Share | 1.78 |
Working Capital | 163.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$133.11 million and capital expenditures -$2.65 million, giving a free cash flow of -$135.77 million.
Operating Cash Flow | -133.11M |
Capital Expenditures | -2.65M |
Free Cash Flow | -135.77M |
FCF Per Share | -$1.46 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,655.02% |
Pretax Margin | -1,801.03% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.28% |
Shareholder Yield | -4.28% |
Earnings Yield | -90.46% |
FCF Yield | -74.76% |
Analyst Forecast
The average price target for CRBU is $6.67, which is 242.05% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.67 |
Price Target Difference | 242.05% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 171.34% |
EPS Growth Forecast (5Y) | -13.58% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of -3.17 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.17 |
Piotroski F-Score | 1 |